Ephedrine and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Chronic obstructive pulmonary disease is reported as a side effect among people who take Ephedrine (ephedra), especially for people who are male, 60+ old, also take Gemfibrozil, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Chronic obstructive pulmonary disease when taking Ephedrine. It is created by eHealthMe based on reports of 1,683 people who have side effects when taking Ephedrine from the FDA, and is updated regularly.

What is Ephedrine?

Ephedrine has active ingredients of ephedra. It is often used in weight loss. eHealthMe is studying from 1,763 Ephedrine users. Check the latest studies of Ephedrine.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,807 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.

On Jul, 13, 2026

1,683 people reported to have side effects when taking Ephedrine.
Among them, 24 people (1.43%) have Chronic obstructive pulmonary disease.

Could Ephedrine cause Chronic obstructive pulmonary disease?

Among these 24 people:

What is the gender of people who have Chronic obstructive pulmonary disease when taking Ephedrine? *

female: 12.5 %
male: 87.5 %

What is the age of people who have Chronic obstructive pulmonary disease when taking Ephedrine? *

What are other drugs people take besides Ephedrine? *

What are other side effects people have besides Chronic obstructive pulmonary disease? *

Chest Pain: 23 people, 95.83%
Ventricular Hypertrophy (enlargement of ventricles (lower chambers) in the heart): 22 people, 91.67%
Dizziness: 21 people, 87.50%
Anaemia (lack of blood): 21 people, 87.50%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 21 people, 87.50%
Fatigue (feeling of tiredness): 21 people, 87.50%
Umbilical Hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button): 21 people, 87.50%
Fainting (loss of consciousness and postural tone): 21 people, 87.50%
Muscle Spasms (muscle contraction): 20 people, 83.33%
Multiple Myeloma (cancer of the plasma cells): 20 people, 83.33%

What are the existing conditions these people have? *

Fluid Retention (an abnormal accumulation of fluid in the blood): 20 people, 83.33%
Multiple Myeloma (cancer of the plasma cells): 20 people, 83.33%
Mood Swings (an extreme or rapid change in mood): 20 people, 83.33%
Joint Pain: 20 people, 83.33%
Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 20 people, 83.33%
Diarrhea: 20 people, 83.33%
High Blood Pressure: 20 people, 83.33%
High Blood Cholesterol: 20 people, 83.33%
Seasonal Allergy (allergic condition due to certain season): 17 people, 70.83%
Blood Triglycerides Decreased: 17 people, 70.83%

* Approximation only. Some reports may have incomplete information.

Do you take Ephedrine and have Chronic obstructive pulmonary disease?

- Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ephedrine:

Ephedrine (1,763 reports)

Browse all side effects of Ephedrine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (1,807 drugs)

Browse all the conditions that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (2,206 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ephedra (the active ingredients of Ephedrine) and Ephedrine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.